«

»

Nov 18

A late-stage drug development business specific in endocrine and oncology therapy.

Fully diluted talk about count is founded on most recent share price. First quarter 2014 Conference Call THE BUSINESS will host a meeting call at 10:00 a.m. Eastern Time on Tuesday, May 6, 2014, to discuss first quarter 2014 outcomes followed by a Q&A program. The domestic call-in quantity is 800-768-6570 and the worldwide call-in number is 785-830-1942. The confirmation code for all callers is normally 5699967. The URL for the webcast is.. Aeterna Zentaris presents positive data from AEZS-108 Phase 2 research in ovarian malignancy at ASCO 2010 Encouraging trend seen in overall survival Aeterna Zentaris Inc. , , a late-stage drug development business specific in endocrine and oncology therapy, announced that it presented positive efficacy and security data for its doxorubicin targeted conjugate compound today, AEZS-108, in ovarian cancer.As a result, the Clonmel site offers achieved significant increases in efficiency, while maintaining the highest standards of quality since it brings innovative medical technologies to the market. Receiving the very best Shingo Prize for our manufacturing unit in Clonmel is normally a testament to the deep dedication of our employees also to our ongoing focus on serving the individuals who benefit from our products. .

Benefits of Porcelain Veneers A smile is manufactured attractive by several aspects. A healthy-looking smile comprises pearly white teeth that are correctly aligned without crookedness, and without unsightly spaces that may make the smile appear unhealthy. Cosmetic dentistry remedies such as teeth whitening and orthodontics work on solving the imperfections of a smile to make it look more gorgeous.